BOTHWELL IAN T 4

What Happened

• Ian T. Bothwell, a 10% owner of Zeo ScientifiX, was awarded two stock option grants on 2026-06-10: 625,000 options (Grant A) and 625,000 options (Grant B), for a total of 1,250,000 options. The filing records $0 acquisition value because these are option awards (derivative securities), not purchases of common stock.

Key Details

• Transaction date: 2026-06-10; Filing date: 2026-06-12 (appears timely).
• Reported price: $0.00 (reflects grant of derivative securities, not a cash purchase).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes:
  • F1: One option grant vested in full as of the grant date and is exercisable on a cashless basis for 10 years from the award date.
  • F2: The other grant vests upon achievement of specified performance milestones, is exercisable cashless once vested for up to 10 years, and is antidilutive for any future transaction issuing ≥10% of the company's fully diluted common stock.
• Transaction type: Award/Grant of options (derivative transaction), not a sale or open-market purchase.

Context

• These are option awards (derivatives). “Cashless” exercise generally allows the holder to convert options into net shares without paying cash up front (the company withholds shares to cover exercise price/taxes), but does not guarantee an immediate sale or cash proceeds.
• As a 10% owner, Bothwell is a principal holder; such awards affect insider ownership but are not the same signal as an outright purchase or sale of common stock.